|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 20759361.7 (espacenet) (Federated) (European Patent Register), 20200217 | | Patent/reg. no. and date | DK/EP 3927347, 20231227 | | Publication date | 20211229 | | Priority no. and date | SE 1950202, 20190218 | | EP pub. no. and date |
EP 3927347 20211229 | | Effective date | | | Applicant/owner | Medivir Aktiebolag, P.O. Box 1086
141 22 Huddinge, SE | | Applicant ref. no. | | | Inventor | ALBERTELLA, Mark, c/o Medivir Aktiebolag Box 1086
141 22 HUDDINGE, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 31/675 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | | Title | METHODS FOR TREATING LIVER CANCERS USING AN ORALLY ADMINISTERED DIOXOLANE NUCLEOTIDE IN COMBINATION WITH AN ANTI-PD1 OR ANTI-PDL1 MONOCLONAL ANTIBODY | | Int. application no. | SE2020050175 | | Int. publication no. | WO2020171757 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
